:

Muhammad Masroor Hussain1,2, Sana Qammar3, Ju-Mei Wang1,2

  • 1Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.

PubMed
概括

胆道癌 (BTC) 的全身疗法正在发展,有针对性的治疗和免疫疗法显示出希望. 以分子生物标志物为指导的个性化医学是改善这些侵袭性恶性瘤的生存率的关键.